Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,775 public trials 502 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors

NCT03708328

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +35 more
Locations
  • Columbia Univ Med Ctr New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Herlev Hospital Herlev, Denmark
  • Rigshospitalet København Ø, Denmark
View all 17 locations
View Trial Details
Completed

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

NCT05259696

Conditions
Adnexal Diseases, Bladder Cancer, Breast Cancer, +68 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Health Care Stanford, California, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 13 locations
View Trial Details
Completed

Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies

NCT03126110

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +82 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University - Siteman Cancer Center St Louis, Missouri, United States
View all 38 locations
View Trial Details
Completed

A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

NCT02327078

Conditions
Adnexal Diseases, Astrocytoma, B-cell Malignancies, +53 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • UCSF - University of California San Francisco San Francisco, California, United States
View all 24 locations
View Trial Details
Completed

Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer

NCT02475213

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +24 more
Locations
  • Mayo Clinic - AZ Scottsdale, Arizona, United States
  • Christiana Care Health Services, Inc. Newark, Delaware, United States
  • Mayo Clinic - FL Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 20 locations
View Trial Details

Related conditions